CA2431778A1 - Rapid imunoassay for multiple detection of hiv1+2 antibodies and p24 antigen - Google Patents
Rapid imunoassay for multiple detection of hiv1+2 antibodies and p24 antigen Download PDFInfo
- Publication number
- CA2431778A1 CA2431778A1 CA 2431778 CA2431778A CA2431778A1 CA 2431778 A1 CA2431778 A1 CA 2431778A1 CA 2431778 CA2431778 CA 2431778 CA 2431778 A CA2431778 A CA 2431778A CA 2431778 A1 CA2431778 A1 CA 2431778A1
- Authority
- CA
- Canada
- Prior art keywords
- test
- immunoassay
- zone
- hiv1
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000001514 detection method Methods 0.000 title claims description 8
- 239000000427 antigen Substances 0.000 title claims description 7
- 102000036639 antigens Human genes 0.000 title claims description 7
- 108091007433 antigens Proteins 0.000 title claims description 7
- 238000003018 immunoassay Methods 0.000 claims description 16
- 238000011144 upstream manufacturing Methods 0.000 claims description 8
- 238000003556 assay Methods 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical group [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 238000003317 immunochromatography Methods 0.000 claims description 2
- 239000012780 transparent material Substances 0.000 claims description 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims 5
- 101710145634 Antigen 1 Proteins 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Description
Rapid Imunoassay for Multiple Detection of HIV 1+2 Antibodies and p24 Antigen1. A rapid cliagnostic immunoassay for multiple detection of HIV 1+2 antibodies and p24 antigen comprising:
a rapid test strip with an upstream end and a downstream end, wherein the test sample flows from upstream end towards downstream end, and wherein said strip has two test zones and one control zone with one said test zone contains HIV
1+2 antigen for detection of HIV 1+2 antibodies, the other said test zone contains McAb against p24 for detection of p24 antigen, and said control zone is for the validity checking of said immunoassay.
a rapid test strip with an upstream end and a downstream end, wherein the test sample flows from upstream end towards downstream end, and wherein said strip has two test zones and one control zone with one said test zone contains HIV
1+2 antigen for detection of HIV 1+2 antibodies, the other said test zone contains McAb against p24 for detection of p24 antigen, and said control zone is for the validity checking of said immunoassay.
2. The immunoassay of claim l, wherein said test zones and control zone are arranged with the following order from said upstream end to downstream end:
(a) the HIVl+2 test zone, (b) the p24 test zone, and (c) the control zone.
(a) the HIVl+2 test zone, (b) the p24 test zone, and (c) the control zone.
3. The immunoassay of claim 1, wherein said test zones and control zone are arranged with the following order from said upstream end to downstream end:
(a) the p24 test zone, (b) the HIV 1+2 test zone, and (c) the control zone.
(a) the p24 test zone, (b) the HIV 1+2 test zone, and (c) the control zone.
4. The immunoassay of claim 1, wherein said rapid immunoassay is colloidal gold immunochromatography assay.
5. The immunoassay of claim 1, 2, 3, and 4, wherein said immunoassay further comprising a housing which has openings and/or with transparent materials to receive said test samples and read the result from said test zones and control zone.
Claims (5)
1. A rapid diagnostic immunoassay for multiple detection of HIV1+2 antibodies and p24 antigen comprising:
a rapid test strip with an upstream end and a downstream end, wherein the test sample flows from upstream end towards downstream end, and wherein said strip has two test zones and one control zone with one said test zone contains HIV1+2 antigen for detection of HIV1+2 antibodies, the other said test zone contains McAb against p24 for detection of p24 antigen, and said control zone is for the validity checking of said immunoassay.
a rapid test strip with an upstream end and a downstream end, wherein the test sample flows from upstream end towards downstream end, and wherein said strip has two test zones and one control zone with one said test zone contains HIV1+2 antigen for detection of HIV1+2 antibodies, the other said test zone contains McAb against p24 for detection of p24 antigen, and said control zone is for the validity checking of said immunoassay.
2. The immunoassay of claim 1, wherein said test zones and control zone are arranged with the following order from said upstream end to downstream end:
(a) the HIV1+2 test zone, (b) the p24 test zone, and (c) the control zone.
(a) the HIV1+2 test zone, (b) the p24 test zone, and (c) the control zone.
3. The immunoassay of claim 1, wherein said test zones and control zone are arranged with the following order from said upstream end to downstream end:
(a) the p24 test zone, (b) the HIV1+2 test zone, and (c) the control zone.
(a) the p24 test zone, (b) the HIV1+2 test zone, and (c) the control zone.
4. The immunoassay of claim 1, wherein said rapid immunoassay is colloidal gold immunochromatography assay.
5. The immunoassay of claim 1, 2, 3, and 4, wherein said immunoassay further comprising a housing which has openings and/or with transparent materials to receive said test samples and read the result from said test zones and control zone.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2431778 CA2431778A1 (en) | 2003-06-19 | 2003-06-19 | Rapid imunoassay for multiple detection of hiv1+2 antibodies and p24 antigen |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2431778 CA2431778A1 (en) | 2003-06-19 | 2003-06-19 | Rapid imunoassay for multiple detection of hiv1+2 antibodies and p24 antigen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2431778A1 true CA2431778A1 (en) | 2004-12-19 |
Family
ID=33557601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2431778 Abandoned CA2431778A1 (en) | 2003-06-19 | 2003-06-19 | Rapid imunoassay for multiple detection of hiv1+2 antibodies and p24 antigen |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2431778A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1798556A1 (en) * | 2005-12-14 | 2007-06-20 | The Jordanian Pharmaceutical Manufacturing Co. | Device for the early and rapid immunochromatographic detection of HIV and uses thereof |
| EP1882943A1 (en) * | 2006-07-27 | 2008-01-30 | The Jordanian Pharmaceutical Manufacturing Co. | Saliva immunochromatographic detection cup |
| CN102680690A (en) * | 2011-03-17 | 2012-09-19 | 北京易斯威特生物医学科技有限公司 | Fourth-generation HIV (Human Immunodeficiency Virus) antibody antigen test paper, preparation method and application thereof |
-
2003
- 2003-06-19 CA CA 2431778 patent/CA2431778A1/en not_active Abandoned
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1798556A1 (en) * | 2005-12-14 | 2007-06-20 | The Jordanian Pharmaceutical Manufacturing Co. | Device for the early and rapid immunochromatographic detection of HIV and uses thereof |
| WO2007068310A1 (en) * | 2005-12-14 | 2007-06-21 | The Jordanian Pharmaceutical Manufacturing Co. | Device for the early and rapid immunochromatographic detection of hiv and uses thereof |
| EP1882943A1 (en) * | 2006-07-27 | 2008-01-30 | The Jordanian Pharmaceutical Manufacturing Co. | Saliva immunochromatographic detection cup |
| WO2008011926A1 (en) * | 2006-07-27 | 2008-01-31 | The Jordanian Pharmaceutical Manufacturing Co. | Saliva immunochromatographic detection cup |
| CN102680690A (en) * | 2011-03-17 | 2012-09-19 | 北京易斯威特生物医学科技有限公司 | Fourth-generation HIV (Human Immunodeficiency Virus) antibody antigen test paper, preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0733211B1 (en) | Interrupted-flow assay device | |
| CA2330100A1 (en) | Ligand binding assay and kit with a separation zone for disturbing analytes | |
| WO2002039114A3 (en) | Improved assay and reagents or immunological determination of analyte concentration | |
| CY1105739T1 (en) | TEST FOR ANTI-TRANSGLUTAMINASE ANTIBODIES | |
| DE69623458D1 (en) | ONE-STAGE IMMUNOCHROMATOGRAPHIC DEVICE AND METHOD FOR USE THEREOF | |
| DE69423896D1 (en) | TEST DEVICE WITH CAPTURED PARTICLE REAGENT | |
| EP1834179A1 (en) | Lab-on-a-chip for an on-the-spot analysis and signal detection methods for the same | |
| DE69815365D1 (en) | DIAGNOSTIC DEVICE FOR CONTROLLED MOVEMENT OF REAGENTS WITHOUT MEMBRANES | |
| BR9807435A (en) | Immunoassay cassette for use in detecting an analyte in a sample of body fluid | |
| CA2396116A1 (en) | Immunochromatographic assay devices with separators | |
| ATE221997T1 (en) | IMMUNOASSAYS FOR THE DETECTION OF ANTIPHOSPHOLIPIDE ANTIBODIES | |
| RU2004122925A (en) | INTERNAL CALIBRATION SYSTEM OF FLOW TEST SYSTEMS | |
| AU2015241521B2 (en) | Immunoassay utilizing trapping conjugate | |
| TR200000921T2 (en) | Assay device for determining analytes in a liquid dairy product | |
| DK196282A (en) | METHOD AND KIT FOR DETERMINING ANTIBODIES AGAINST SOLUBLE ANTIGENS | |
| NO20003709D0 (en) | Detection system using liposomes and signal modification | |
| CA2431778A1 (en) | Rapid imunoassay for multiple detection of hiv1+2 antibodies and p24 antigen | |
| EP0346119A3 (en) | Anti-fc assay for detection of antibodies | |
| KR200394358Y1 (en) | Immunoassay device capable of performing several immunoassays | |
| JP2005037385A (en) | Device for immunochromatography | |
| JP4344743B2 (en) | Immunoassay test equipment | |
| CN101175996A (en) | Semi-quantitative immunochromatographic device | |
| WO2004040306A1 (en) | Diagnostic device and kit | |
| AU2001250470A1 (en) | Novel antibodies specifically identifying inactive psa, and uses thereof | |
| CA2431777A1 (en) | Rapid imunoassay for multiple detection of hepatitis b antigens and antibodies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |